Posted in | News

Renishaw’s RA802 Pharmaceutical Analyser shortlisted in the CPhI Pharma Awards

Renishaw is delighted to have its RA802 Pharmaceutical Analyser shortlisted for a 2018 CPhI Pharma Award.

The CPhI Pharma Awards, which are now in their 15th year, provide recognition to pharmaceutical companies that turn inspiration into innovation. They celebrate thinkers and creators breaking new ground in the industry and strongly advocate companies that are committed to driving the industry forward.

The RA802 Pharmaceutical Analyser has been shortlisted in the Analysis, Testing, and Quality Control category. The winners will be announced during the CPhI Pharma Awards Gala, which takes place during the annual CPhI Worldwide conference, between 9-11th October, in Madrid, Spain. This event attracts the world’s most prominent pharma executives, who gather for three days of collaboration, information dissemination and discussions that will help to define the future of the industry.

“We’re absolutely delighted that our benchtop instrument has been recognised for its innovation”, said Ken Williams, Director and General Manager of Renishaw’s Spectroscopy Products Division. “It is the only dedicated high-speed Raman imaging system designed for pharmaceutical analysis, helping scientists tackle formulation challenges and expedite drug development.”

The RA802 enables users to formulate tablets more efficiently by speeding up the analysis of tablet composition and structure. It brings together the chemical analysis power of Raman spectroscopy and advanced imaging technologies in a powerful, robust system. Users can reveal detailed chemical and physical information about the contents of their sample, from the distribution and size of API domains to the physical topography. The RA802 makes the highest performance Raman spectroscopy accessible to all users.

Please visit www.renishaw.com/RA802 for further information about the RA802 Pharmaceutical Analyser.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Renishaw plc - Spectroscopy. (2018, September 24). Renishaw’s RA802 Pharmaceutical Analyser shortlisted in the CPhI Pharma Awards. AZoM. Retrieved on February 28, 2024 from https://www.azom.com/news.aspx?newsID=49701.

  • MLA

    Renishaw plc - Spectroscopy. "Renishaw’s RA802 Pharmaceutical Analyser shortlisted in the CPhI Pharma Awards". AZoM. 28 February 2024. <https://www.azom.com/news.aspx?newsID=49701>.

  • Chicago

    Renishaw plc - Spectroscopy. "Renishaw’s RA802 Pharmaceutical Analyser shortlisted in the CPhI Pharma Awards". AZoM. https://www.azom.com/news.aspx?newsID=49701. (accessed February 28, 2024).

  • Harvard

    Renishaw plc - Spectroscopy. 2018. Renishaw’s RA802 Pharmaceutical Analyser shortlisted in the CPhI Pharma Awards. AZoM, viewed 28 February 2024, https://www.azom.com/news.aspx?newsID=49701.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.